GlaxoSmithKline PLC News Headlines

GSK 
$43.35
*  
0.06
0.14%
Get GSK Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading GSK now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
The Most Disappointing Clinical Failures in 2014
12/21/2014 7:32:02 PM - Motley Fool


Exciting News: A Game-Changing Shingles Vaccine Could Be On Its Way
12/21/2014 7:14:03 AM - Motley Fool


Tax-Loss Selling: 1 Stock We'd Be Glad to Sell Right Now
12/20/2014 5:05:03 PM - Motley Fool


The Early Retiree Portfolio For 2015
12/19/2014 6:17:00 PM - Seeking Alpha


Agenus Jumps on Positive Data from Shingles Candidate - Analyst Blog
12/19/2014 4:09:00 PM - Zacks.com


Seeking Alpha's Biotech Weekly: A Merck Purchase, Spectacular Auspex, And More
12/19/2014 4:00:00 PM - Seeking Alpha


Doug Loe: Canada Has Earned Its Spot In The Biotech All-Star Team Photo
12/19/2014 10:53:00 AM - Seeking Alpha


Agenus Jumps on Positive Data from Shingles Candidate - Analyst Blog
12/19/2014 4:09:00 AM - Investopedia


GlaxoSmithKline (GSK) Stock Rises Today on Positive Experimental Shingles Vaccine Trial Results
12/18/2014 3:11:00 PM - TheStreet


Complex Sino-U.S. Ties Shine In Avon, Solar And Qualcomm Cases
12/18/2014 12:49:00 PM - Seeking Alpha


GlaxoSmithKline Shingles Vaccine Meets Primary Endpoint - Quick Facts
12/18/2014 8:11:00 AM - RTT News


GlaxoSmithKline Shareholders Pass Deal With Novartis By Overwhelming Majority
12/18/2014 8:06:00 AM - RTT News


Agenus: GSK's ZOE-50 Phase 3 Study Meets Primary Endpoint - Quick Facts
12/18/2014 7:12:00 AM - RTT News


Vanguard FTSE Europe ETF Experiences Big Outflow
12/17/2014 11:09:27 AM - BNK Invest


Roche Submitted NDA for Melanoma Combination Drug - Analyst Blog
12/16/2014 6:30:00 PM - Zacks.com


3 Beaten Down Stocks Ready to Bounce Back
12/16/2014 8:48:03 AM - Motley Fool


3 Reasons GlaxoSmithKline PLC Could Soar in 2015
12/16/2014 8:03:02 AM - Motley Fool


Roche Submitted NDA for Melanoma Combination Drug - Analyst Blog
12/16/2014 6:30:00 AM - Investopedia


3 Stocks That Might Slash Their Dividends in 2015
12/14/2014 12:47:02 PM - Motley Fool


This Tiny Biotech Worries Sanofi and Shire, and Vexes GlaxoSmithKline
12/14/2014 9:28:03 AM - Motley Fool


Gavi gives Ebola vaccine developers an extra incentive to move quickly
12/11/2014 11:58:00 AM - Seeking Alpha


GlaxoSmithKline Seeks Variation on Authorization for Ambrisentan
12/11/2014 7:32:00 AM - Dow Jones Business News


Will The New HPV Vaccine Prove A Shot In The Arm For Merck?
12/10/2014 9:46:00 PM - RTT News


Health Care Stocks: A Year in Review and Predictions for 2015
12/10/2014 11:38:00 AM - TheStreet


Pre-Market Most Active for Dec 10, 2014 : KB, FCAU, TVIX, GSK, BHP, AAPL, S, TMUS, FRAN, XIV, QQQ, AAL
12/10/2014 8:39:45 AM - NASDAQ.com News